1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analysts (LPA) Jey Cardenas conducted a subsequent complaint visit to deliver findings for the allegation listed above. Upon arrival at the facility LPA conducted a risk assessment over the telephone with administrator, Sue Cooper; based on the assessment, the facility is clear of Covid-19 infection. LPA met with Miss Cooper, the purpose of the visit was explained.
Investigation consisted of: LPA toured physical plant, conducted interviews with Administrator, Miss Cooper and staff, reviewed resident files and medication.
It is alleged that the facility was requesting an early refill for Resident 1 (R1) Risperidone liquid because the facility uses the medication for other resident living at the facility.
Re: allegation Staff mishandles a resident's medication. On 7/26/21 LPA Cardenas reviewed residents Medication administration Record (MAR) and observed that R1 and R2 both have prescription for Risperidone. Per doctors’ orders R1 Risperidone should be given .125ML by mouth two times a day, |